Oral oseltamivir treatment of influenza in children

By R. Whitley, F. Hayden, K. Reisinger, N. Young, R. Dutkowski, D. Ipe, R. Mills, P. Ward. The Pediatric Infectious Disease Journal, 2001

739 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Epidemiology

View Paper: https://www.semanticscholar.org/paper/e1b6a386d01361cecce61fffde1634511b8bd90d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. P. Palese
2. F. Krammer
3. A. García‐Sastre
4. R. Webster
5. J. Taubenberger
6. Jesse D. Bloom

Citations in the corpus

• Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). (2011, background): “Data from human clinical studies have indicated that zanamivir and oseltamivir have activity against influenza B viruses (21,116,145,155,156).”
• Influenza (2018, background): “Children can shed virus for 10 days or more (39).”